Kipp Erickson has been named director of clinical research and translational medicine in the Michigan State University College of Veterinary Medicine’s Office of Research and Graduate Studies. The newly created position will help advance the health and well-being of both animals and humans.
Erickson will act as the college’s internal resource for campus-wide, academic drug discovery, technology innovation and product development, and also mentor and foster inclusivity between colleges by encouraging partnerships in research.
“Our goal is to nurture our basic science studies toward innovative findings and pathways and to increase the college’s support toward progressing these findings in its own clinical research while connecting our world-class expert community with external partners that will help us all capitalize on opportunities for animal and human health,” Erickson said.
Erickson’s experience in the pharmaceutical industry, both in human and animal drug discovery, as well as commercial product development, will help him with plans to establish a new clinical trial and research study initiative. This effort will connect the college’s research scientists and clinicians to animal health companies and their drug development programs.
Participating in therapeutic drug development with industry partners will offer early access to new medicines, better healthcare decision making and academic development for all its healthcare professionals and students.
“In today’s world of rapidly advancing biomedical knowledge, we have the opportunity and the responsibility to facilitate translation of this knowledge to improve the health and wellbeing of animals and humans,” said Vilma Yuzbasiyan-Gurkan, associate dean for research and graduate studies. “We’re excited to pursue new partnerships that will help us continue affecting change in animal and human health at a greater pace than ever before. I am excited to have Dr. Erickson on board to help us work more effectively toward these goals.”
SOURCE: MSU Today